Zn deficiency in GC patients was associated with poor prognosis and may promote tumor progression by disrupting PI3K–AKT, NF-κB, and Wnt/β-catenin signaling pathways and impairing immune-related kinase functions (47). This evidence concerns the gene NFKB1 and neoplasm.